📰 Medication Guide News

Page 4 - Medication Guide News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Medication Guide. Real-time updates on events, politics, business and more.

How One Mother's Perseverance with Psoriatic Disease Helped Turn Challenge into Purpose

February 9, 2024

(BPT) - For those living with plaque psoriasis (PsO) and active psoriatic arthritis (PsA) — known collectively as psoriatic disease[1] — every day can feel like a challenge. From PsO

United States National Psoriasis Foundation Functional Assessment Chronic Illness Therapy Important Safety Information Medication Guide

Source: whig.com

How One Mother's Perseverance with Psoriatic Disease Helped Turn Challenge into Purpose

February 8, 2024

(BPT) - For those living with plaque psoriasis (PsO) and active psoriatic arthritis (PsA) — known collectively as psoriatic disease[1] — every day can feel like a challenge. From PsO

United States National Psoriasis Foundation Functional Assessment Chronic Illness Therapy Important Safety Information Medication Guide

Source: yankton.net

Merck's KEYTRUDA® (pembrolizumab) Reduced the Risk of Death by 38% Versus Placebo as Adjuvant Therapy for Patients With Renal Cell Carcinoma (RCC) at an Increased Risk of Recurrence Following Nephrectomy -January 27, 2024 at 10:01 am EST

January 27, 2024

KEYNOTE-564 is the first Phase 3 trial to demonstrate superior overall survival with adjuvant therapy compared to placebo in patients with RCC Late-breaking OS results selected for the official...

United States Tonik Choueiri Nancy Kohlberg Harvard Medical School Exchange Commission Asco Gu Press Program

Source: marketscreener.com

Merck's KEYTRUDA® (pembrolizumab) Reduced the Risk of Death by 38% Versus Placebo as Adjuvant Therapy for Patients With Renal Cell Carcinoma (RCC) at an Increased Risk of Recurrence Following Nephrectomy | Region

January 27, 2024

RAHWAY, N.J.--(BUSINESS WIRE)--Jan 27, 2024--

United States Michael Mcardle Peter Dannenbaum Damini Chokshi Nancy Kohlberg Tonik Choueiri

Source: eagletribune.com

Merck's KEYTRUDA® (pembrolizumab) Reduced the Risk of Death by 38% Versus Placebo as Adjuvant Therapy for Patients With Renal Cell Carcinoma (RCC) at an Increased Risk of Recurrence Following Nephrectomy | Business

January 27, 2024

RAHWAY, N.J.--(BUSINESS WIRE)--Jan 27, 2024--

United States Peter Dannenbaum Damini Chokshi Tonik Choueiri Michael Mcardle Nancy Kohlberg

Source: valdostadailytimes.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

FDA: Safety Label Changes Required for BCMA-, CD19-Directed CAR T-Cell Therapies

January 26, 2024

The FDA is requiring new safety information be included in the labeling for all BCMA- or CD19-directed autologous CAR T-cell immunotherapies.

Drug Administration Boxed Warning Patient Counseling Information Medication Guide

Source: oncologynurseadvisor.com

FDA warns of secondary cancer risk tied to CAR-T therapies that treat cancer

January 25, 2024

The US Food and Drug Administration has issued a new warning about the possible risk of secondary cancers in cancer patients who have been treated with a form of immunotherapy

United States Mikkael Sekeres Carly Pflaum Peter Marks Eric Smith Joshua Brody

Source: phillytrib.com

Endo Announces Publication of New XIAFLEX® (collagenase clostridium histolyticum) Survey Data in Journal of Hand Surgery Global Open

January 24, 2024

/PRNewswire/ -- Endo International plc (OTC: ENDPQ) announced today that the peer-reviewed Journal of Hand Surgery Global Open published Collagenase...

Garym Pess Clin Rheumatol Endo International Prnewswire Endo International Endo Pharmaceuticals Inc Exchange Commission

Source: prnewswire.com